Ranibizumab for Diabetic Traction Retinal Detachment
Status:
Completed
Trial end date:
2010-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study was to assess the effect of ranibizumab in reducing intraoperative
vitreous haemorrhage during pars plana vitrectomy, thus facilitating surgery and improving
its anatomical and functional results in patients with advanced proliferative diabetic
retinopathy and traction retinal detachment.